PSNL
Price
$6.04
Change
+$0.05 (+0.84%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
530.29M
40 days until earnings call
STXS
Price
$2.92
Change
-$0.00 (-0.00%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
265.92M
41 days until earnings call
Interact to see
Advertisement

PSNL vs STXS

Header iconPSNL vs STXS Comparison
Open Charts PSNL vs STXSBanner chart's image
Personalis
Price$6.04
Change+$0.05 (+0.84%)
Volume$18.62K
Capitalization530.29M
Stereotaxis
Price$2.92
Change-$0.00 (-0.00%)
Volume$744
Capitalization265.92M
PSNL vs STXS Comparison Chart in %
Loading...
PSNL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PSNL vs. STXS commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PSNL is a StrongBuy and STXS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (PSNL: $6.03 vs. STXS: $2.92)
Brand notoriety: PSNL and STXS are both not notable
PSNL represents the Medical Specialties, while STXS is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: PSNL: 48% vs. STXS: 13%
Market capitalization -- PSNL: $530.29M vs. STXS: $265.92M
PSNL [@Medical Specialties] is valued at $530.29M. STXS’s [@Pharmaceuticals: Other] market capitalization is $265.92M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $157.06B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.33B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PSNL’s FA Score shows that 0 FA rating(s) are green whileSTXS’s FA Score has 0 green FA rating(s).

  • PSNL’s FA Score: 0 green, 5 red.
  • STXS’s FA Score: 0 green, 5 red.
According to our system of comparison, PSNL is a better buy in the long-term than STXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PSNL’s TA Score shows that 5 TA indicator(s) are bullish while STXS’s TA Score has 3 bullish TA indicator(s).

  • PSNL’s TA Score: 5 bullish, 5 bearish.
  • STXS’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both PSNL and STXS are a good buy in the short-term.

Price Growth

PSNL (@Medical Specialties) experienced а -1.07% price change this week, while STXS (@Pharmaceuticals: Other) price change was +4.09% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.12%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +24.86%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.23%. For the same industry, the average monthly price growth was -3.27%, and the average quarterly price growth was +8.57%.

Reported Earning Dates

PSNL is expected to report earnings on Nov 05, 2025.

STXS is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Medical Specialties (-0.12% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-1.23% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PSNL($530M) has a higher market cap than STXS($266M). STXS YTD gains are higher at: 28.289 vs. PSNL (4.412). STXS has higher annual earnings (EBITDA): -22.41M vs. PSNL (-80.8M). PSNL has more cash in the bank: 173M vs. STXS (6.97M). STXS has less debt than PSNL: STXS (5.73M) vs PSNL (42.4M). PSNL has higher revenues than STXS: PSNL (80.3M) vs STXS (31.8M).
PSNLSTXSPSNL / STXS
Capitalization530M266M199%
EBITDA-80.8M-22.41M361%
Gain YTD4.41228.28916%
P/E RatioN/AN/A-
Revenue80.3M31.8M253%
Total Cash173M6.97M2,483%
Total Debt42.4M5.73M740%
FUNDAMENTALS RATINGS
PSNL vs STXS: Fundamental Ratings
PSNL
STXS
OUTLOOK RATING
1..100
1981
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
4040
P/E GROWTH RATING
1..100
10054
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PSNL's Valuation (42) in the null industry is somewhat better than the same rating for STXS (100) in the Medical Specialties industry. This means that PSNL’s stock grew somewhat faster than STXS’s over the last 12 months.

PSNL's Profit vs Risk Rating (100) in the null industry is in the same range as STXS (100) in the Medical Specialties industry. This means that PSNL’s stock grew similarly to STXS’s over the last 12 months.

PSNL's SMR Rating (98) in the null industry is in the same range as STXS (100) in the Medical Specialties industry. This means that PSNL’s stock grew similarly to STXS’s over the last 12 months.

PSNL's Price Growth Rating (40) in the null industry is in the same range as STXS (40) in the Medical Specialties industry. This means that PSNL’s stock grew similarly to STXS’s over the last 12 months.

STXS's P/E Growth Rating (54) in the Medical Specialties industry is somewhat better than the same rating for PSNL (100) in the null industry. This means that STXS’s stock grew somewhat faster than PSNL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PSNLSTXS
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 10 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
PSNL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HMCRX15.18N/A
N/A
Harbor Mid Cap Retirement
GATCX43.19N/A
N/A
Gabelli Asset C
JBATX31.27N/A
N/A
JHancock Balanced R2
RBCRX12.48N/A
N/A
RBC China Equity R6
RPPRX30.93N/A
N/A
Victory RS Partners R6

PSNL and

Correlation & Price change

A.I.dvisor indicates that over the last year, PSNL has been loosely correlated with CRL. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PSNL jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PSNL
1D Price
Change %
PSNL100%
+0.92%
CRL - PSNL
42%
Loosely correlated
+2.04%
BLFS - PSNL
42%
Loosely correlated
+2.07%
CERS - PSNL
40%
Loosely correlated
-4.64%
CLPT - PSNL
39%
Loosely correlated
+9.25%
VCYT - PSNL
39%
Loosely correlated
+1.89%
More

STXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, STXS has been loosely correlated with TWST. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if STXS jumps, then TWST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STXS
1D Price
Change %
STXS100%
+0.17%
TWST - STXS
37%
Loosely correlated
+0.64%
PSNL - STXS
33%
Loosely correlated
+0.92%
NVST - STXS
33%
Loosely correlated
+1.80%
VCYT - STXS
33%
Poorly correlated
+1.89%
RGEN - STXS
33%
Poorly correlated
+3.25%
More